Page last updated: 2024-11-08

panepoxydone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

panepoxydone: structure given in first source; RN refers to (1S-(1alpha,3(S*),5alpha,6alpha))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10130519
CHEMBL ID116251
MeSH IDM0265733

Synonyms (6)

Synonym
panepoxydone
SMP2_000008
CHEMBL116251
31298-54-1
panepoxydon
(1s,5r,6s)-5-hydroxy-3-[(1r)-1-hydroxy-3-methylbut-2-enyl]-7-oxabicyclo[4.1.0]hept-3-en-2-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID82224Compound was tested for NF-kB inhibitory activity in HEK 293 cells2002Bioorganic & medicinal chemistry letters, Dec-02, Volume: 12, Issue:23
Inhibitors of NF-kappaB signaling: design and synthesis of a biotinylated isopanepoxydone affinity reagent.
AID87771Compound was tested for NF-kB inhibitory activity in Hela M cells2002Bioorganic & medicinal chemistry letters, Dec-02, Volume: 12, Issue:23
Inhibitors of NF-kappaB signaling: design and synthesis of a biotinylated isopanepoxydone affinity reagent.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's2 (22.22)29.6817
2010's5 (55.56)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]